Novo Nordisk’s “Super Ozempic” Trial Disappoints Again Novo Nordisk, a pharmaceutical giant known for its groundbreaking diabetes treatments, recently faced a setback with its highly anticipated next-generation drug, CagriSema. The company’s shares took a hit after the release of disappointing trial results that revealed CagriSema failed to outperform its competitor, Eli Lilly’s Mounjaro. The pharmaceutical […]
Amgen expands in India with $200 million investment
Amgen Expands in India with $200 Million Investment Amgen, a renowned biotechnology company, is making significant strides in its global expansion efforts with a substantial investment in India. The recent announcement of a $200 million investment underscores Amgen’s commitment to strengthening its presence in the Indian pharmaceutical market. This strategic move is poised to not […]
L’Oréal Sells €3 Billion of Sanofi Stock Back to Drugmaker
L’Oréal Sells €3 Billion of Sanofi Stock Back to Drugmaker L’Oréal, the renowned French cosmetics giant, has recently made a strategic move by selling €3 billion of Sanofi stock back to the drugmaker. This significant transaction is not just about reshuffling assets; it signifies a calculated step towards optimizing L’Oréal’s balance sheet. By divesting a […]